Sunaric-Mégevand is medical director of the Florissant Eye Centre and director of the Eye Research Centre at Adolphe de Rothschild Hospital in Geneva, Switzerland. e:[email protected] ...
Presenters highlight clinical insights and lessons from recent trial data and surgical experience On efficacy, Regillo said ...
New real-world data from ASRS 2026 show nearly 40% of wet AMD patients go 180+ days without anti-VEGF treatment within a year ...
REMAIN data show MCO-010 optogenetic therapy delivered durable ~3-line vision gains in retinitis pigmentosa regardless of ...
Ophthalmology is projected to face one of the steepest physician shortages of any subspecialty by 2038. According to an article published in Becker's Hospital Review, a number of medical ...
As director of clinical trials, Sheth has served as principal investigator on more than 100 clinical trials, advancing ...
American College of Physicians recommends moving away from “provider” in policy paper ...
How equitably are glaucoma medications being dispensed across a universal health care system, and how have prescribing ...
A real-world Vestrum database analysis found pegcetacoplan was linked to better visual acuity outcomes in geographic atrophy, ...
Vonaprument reduced the proportion of eyes with clinically meaningful vision loss, though not uniformly across doses. Through ...
Introducing Nicholas Riina, MS. Nicholas Riina, MS, had his eye on the prize early on, growing up in a family in which he was ...
Could FLIO predict how fast geographic atrophy will grow?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results